| Serial Number | 88086645 |
| Word Mark | CLINIPACE CP |
| Filing Date | Tuesday, August 21, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 30, 2019 |
| Registration Number | 5818056 |
| Registration Date | Tuesday, July 30, 2019 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, May 14, 2019 |
| Goods and Services | Contract research organization (CRO) services, namely, custom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports |
| Description of Mark | The mark consists of the stylized wording "CLINIPACE" followed by superscript stylized letters "C" and "P". |
| Pseudo Mark | CLINIC PACE CP |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management |
| Goods and Services | Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields |
| Goods and Services | Contract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, in particular gastroenterology, nephrology, urology, and oncology; consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devices |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 29, 2018 |
| Primary Code | 035 |
| First Use Anywhere Date | Friday, June 22, 2018 |
| First Use In Commerce Date | Friday, June 22, 2018 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 3, 2019 |
| Primary Code | 041 |
| First Use Anywhere Date | Friday, June 22, 2018 |
| First Use In Commerce Date | Friday, June 22, 2018 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 29, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, June 22, 2018 |
| First Use In Commerce Date | Friday, June 22, 2018 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 29, 2018 |
| Primary Code | 045 |
| First Use Anywhere Date | Friday, June 22, 2018 |
| First Use In Commerce Date | Friday, June 22, 2018 |
| Party Name | Clinipace, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Morrisville, NC 27560 |
| Party Name | Clinipace, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Morrisville, NC 27560 |
| Party Name | Clinipace, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Morrisville, NC 27560 |
| Event Date | Event Description |
| Saturday, December 8, 2018 | NON-FINAL ACTION WRITTEN |
| Friday, August 24, 2018 | NEW APPLICATION ENTERED |
| Wednesday, August 29, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 6, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, April 3, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, December 8, 2018 | NON-FINAL ACTION E-MAILED |
| Saturday, December 8, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, December 18, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 21, 2018 | ASSIGNED TO LIE |
| Saturday, December 22, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, December 22, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 14, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, January 14, 2019 | NON-FINAL ACTION E-MAILED |
| Monday, January 14, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, April 5, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, April 3, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 3, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 5, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, April 5, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Friday, April 5, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, April 5, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Friday, April 5, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, May 14, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 24, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 30, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, May 14, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 30, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, February 5, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, February 5, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, February 5, 2025 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, February 5, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 5, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, February 5, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |